AbbVie | ABBV - Current Assets

Stock Price
208.84
Daily Change
-6.14 -2.86%
Monthly
-10.70%
Yearly
3.57%
Q2 Forecast
202.55

AbbVie reported $29.06B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Abbott USD 26B 1.16B Dec/2025
ALKERMES USD 1.93B 187.5M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Coherus Biosciences USD 206.71M 254.25M Dec/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
J&J USD 55.62B 1.01B Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Neurocrine Biosciences USD 2.52B 364.3M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 6.05B 733M Dec/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025
Zoetis USD 6.77B 185M Dec/2025